630
Views
2
CrossRef citations to date
0
Altmetric
State of the Art

Opportunities and challenges in psychopharmacology


Oportunidades y desafíos en psicofarmacología

Opportunités et défis en psychopharmacologie

REFERENCES

  • KlineNS.Clinical experience with iproniazid (Marsilid).J Clin Exp Pathol.195819suppl l1S72S78
  • KuhnR.Über die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355)Schweiz Med Wschrft.19578711351140
  • KleinDFFinkM.Psychiatric reaction patterns to imipramine.Am J Psychiatry.196211943243814033346
  • LaboritH.Sodium 4-hydroxybutyrate.Int J Neuropharmacol.1964343345114334876
  • HornykiewiczO.A brief history of levodopa.J Neurol.2010257suppl 2S249S25221080185
  • ConnollySAnneyRGallagherLHeronEA.A genome-wide investigation into parent-of-origin effects in autism spectrum disorder identifies previously associated genes including SHANK3.Eur J Hum Genet.201725223423927876814
  • FrankOGiehlMZhengCet al.Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.J Virol.20057917108901090116103141
  • HawrylyczMJLeinESGuillozet-Bongaarts ALet al.An anatomically comprehensive atlas of the adult human brain transcriptome.Nature.2012489741639139922996553
  • TasicBYaoZGraybuckLTet al.Shared and distinct transcriptomic cell types across neocortical areas.Nature.20185637729727830382198
  • ArionDHuoZEnwrightJFet al.Transcriptome alterations in prefrontal pyramidal cells distinguish schizophrenia from bipolar and major depressive disorders.Biol Psychiatry.201782859460028476208
  • ArlothJBogdanRWeberPet al.Genetic differences in the immediate transcriptome response to stress predict risk-related brain function and psychiatric disorders.Neuron.20158651189120226050039
  • HeiligMBarbierEJohnstoneALet al.Reprogramming of mPFC transcriptome and function in alcohol dependence.Genes Brain Behav.20171618610027657733
  • ReschkeCRAlmeida SilvaLFNorwoodBAet al.Potent anti-seizure effects of locked nucleic acid antagomirs targeting miR-134 in multiple mouse and rat models of epilepsy.Mol Ther Nucleic Acids.20176455628325299
  • PtakCPetronisA.Epigenetic approaches to psychiatric disorders.Dial Clin Neurosci.20101222535
  • SkinnerMKAnwayMDSavenkovaMIet al.Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior.PLoS One.2008311e374519015723
  • BabenkoOKovalchukIMetzGA.Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health.Neurosci Biobehav Rev.201548709125464029
  • McNabneySMHenaganTM.Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance.Nutrient.20179121348
  • BoksMPde JongNMKasMJHet al.Current status and future prospects for epigenetic psychopharmacology.Epigenetics.201271202822207355
  • KazantsevAGThompsonLM.Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.Nat Rev Drug Discov.2008785486818827828
  • DayJJ.New approaches to manipulating the epigenome.Dialogues Clin Neurosci.201416334535725364285
  • AbelTPoplawskiS.Epigenetic advances in clinical neuroscience.Dialogues Clin Neurosci.2014163272275
  • ChatterjeePRoyDRathiN.Epigenetic drug repositioning for Alzheimer’s disease based on epigenetic targets in human interactome.J Alzheimers Dis.2018611536529199645
  • HobanAEStillingRMMoloneyGet al.Microbial regulation of microRNA expression in the amygdala and prefrontal cortex.Microbiome. 20175110228838324
  • GeaghanMCairnsMJ.MicroRNA and posttranscriptional dysregulation in psychiatry.Biol Psychiatry.201578423123925636176
  • KennyPJ.Epigenetics, microRNA, and addiction.Dialogues Clin Neurosci.201416333534425364284
  • SimonsonBDasS.MicroRNA therapeutics: the next magic bullet?Mini Rev Med Chem.201515646747425807941
  • KumarSReddyPH.Are circulating microRNAs peripheral biomarkers for Alzheimer’s disease?Biochim Biophys Acta.2016186291617162727264337
  • OvedKFarberovLGilamAet al.MicroRNA-mediated regulation of ITGB3 and CHL 1 is implicated in SSRI action.Front Mol Neurosci.20171035529163031
  • PicardMMcEwenBSEpelESet al.An energetic view of stress: Focus on mitochondria.Front Neuroendocrinol.201849728529339091
  • NikiforovAKulikovaVZieglerM.The human NAD metabolome: Functions, metabolism and compartmentalization.Crit Rev Biochem Mol Biol.201550428429725837229
  • Kaddurah-DaoukRYuanPBoyleSHet al.Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile.Sci Rep.2012266722993692
  • FryeRERoseSChackoJet al.Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines.Transl Psychiatry.2016610e92727779624
  • YangJChenTSunLet al.Potential metabolite markers of schizophrenia.Mol Psychiatry.2013181677822024767
  • SteffensDCJiangWKrishnanRRet al.Metabolomic differences in heart failure patients with and without major depression.J Geriatr Psychiatry Neurol.201023213814620101071
  • SavitzJDantzerRWurfelBEet al.Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.Psychoneuroendocrinology.20155220021125486577
  • GardnerABolesRG.Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders.Prog Neuropsychopharmacol Biol Psychiatry.201135373074320691744
  • ScagliaF.The role of mitochondrial dysfunction in psychiatric disease.Dev Disabil Res Rev.201016213614320818728
  • De SousaRTMarchado-VieiraRZarateCAManjiHK.Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.Expert Opin Ther Targets.201418101131114725056514
  • WeckmannKDeeryMJHowardJAet al.Ketamine’s antidepressant effect is mediated by energy metabolism and antioxidant defense system. Sci Rep.201771578829150633
  • PicardMPratherAAPutermanEet al.A Mitochondrial health index sensitive to mood and caregiving stress.Biol Psychiatry.201884191729525040
  • SzetoHH.Pharmacologic approaches to improve mitochondrial function in AKI and CKD.J Am Soc Nephrol.201728102856286528778860
  • Hemachandra ReddyPManczakMKandimallaR.Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease.Hum Mol Genet.20172681483149628186562
  • UittenbogaardMChiaramelloA.Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases.Curr Pharm Des.201420355574559324606804
  • GottwaldEMDussMBugarskiMet al.The targeted anti-oxidant MitoQ causes mitochondrial swelling and depolarization in kidney tissue.Physiol Rep.201867e1366729611340
  • SawdaCMoussaCScott TurnerR.Resveratrol for Alzheimer’s disease.Ann N Y Acad Sci.20171403114214928815614
  • YangSSZhangRWangGZhangYF.The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease.Transl Neurodegener.201761928702178
  • KumarSReddyPH.Are circulating microRNAs peripheral biomarkers for Alzheimer’s disease?Biochim Biophys Acta.2016186291617162727264337
  • CummingsJLeeGMortsdorfTet al.Alzheimer’s disease drug development pipeline: 2017.Alzheimers Dement (NY).201733367384
  • GuestPCGuestFLMartins-de SouzaD.Making sense of blood-based proteomics and metabolomics in psychiatric research.Int J Neuropsychopharmacol.201696110
  • DavidLAMauriceCFCarmodyRNet al.Diet rapidly and reproducibly alters the human gut microbiome.Nature.2014505748455956324336217
  • KellyJRKennedyPJCryanJFet al.Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders.Front Cell Neurosci.2015939226528128
  • RogersGBKeatingDJYoungRLet al.From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.Mol Psychiatry.201621673874827090305
  • SuranaN.Microbiome and translational therapeutics.Dialogues Clin Neurosci.201921215916531636490
  • WilliamsL.Precision psychiatry: a neural circuit taxonomy for depression and anxiety.Lancet Psychiatry.20163547248027150382
  • TagoTToyoharaJ.Advances in the development of PET ligands targeting histone deacetylases for the assessment of neurodegenerative diseases.Molecules.20182330
  • Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse.Drug Alcohol Depend.20151529310125977206
  • Goldstein-PiekarskiANKorgaonkarMSGreenEet al.Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants.PNAS.201611342119551196027791054
  • DusiNBarlatiSVitaAet al.Brain structural effects of antidepressant Treatment in major depression.Curr Neuropharmacol.20151345846526412065
  • FonsekaTMMacQueenGMKennedySH.Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder.J Affect Disord.2018233213529150145
  • HartleyBJBrennandKJ.Neural organoids for disease phenotyping, drug screening and developmental biology studies.Neurochem Int.2017106859327744003
  • TemmeSJMaherBJChristianKM.Using induced pluripotent stem cells to investigate complex genetic psychiatric disorders.Curr Behav Neurosci Rep.20163427528428191386
  • MarchettoMCBelinsonHTianYet al.Altered proliferation and networks in neural cells derived from idiopathic autistic individuals.Mol Psychiatry.201722682083527378147
  • JorfiMD’AvanzoCKimDYet al.Three-dimensional models of the human brain development and diseases.Adv Health Mater.201871 https://doi.org/10.1002/adhm.201700723
  • HaggartySJSilvaMCCrossABrandoNJPerlisRH.Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Mol Cell Neurosci.20167310411526826498
  • ChohanMOMooreH.Interneuron progenitor transplantation to treat CNS dysfunction.Front Neural Circuits.2016106427582692
  • RothBL.DREADDs for Neuroscientists.Neuron.201689468369426889809
  • SongCKnöpfelT.Optogenetics enlightens neuroscience drug discovery.Nat Rev Drug Discov.2016159710926612666
  • DeisserothK.Circuit dynamics of adaptive and maladaptive behavior.Nature.2014505748330931924429629
  • TyeKMMirzabekovJJWardenMRet al.Dopamine neurons modulate neural encoding and expression of depression-related behavior.Nature.201349353754123235822
  • AhmariSESpellmanTDouglassNLet al.Repeated cortico-striatal stimulation generates persistent OCD-like behavior.Science. 201334061371234123923744948
  • CongLRanFACoxDet al.Multiplex Genome Engineering Using CRISPR/Cas Systems.Science.2013339612181982323287718
  • WangPLinMPedrosaEet al.CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment.Molecular Autism.201565526491539
  • PulecioJVermaNMejia-RamirezEet al.CRISPR/Cas9-based engineering of the epigenome.Cell Stem Cell.20172143144728985525
  • SchmaalLHibarDPSämannPGet al.Cortical abnormalities in adults and adolescents with major depression based on brain scans from. 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.Mol Psychiatry.201722690090927137745
  • RollinsBMartinMVMorganLVawterMP.Analysis of whole genome biomarker expression in blood and brain.Am J Med Genet B Neuropsychiatr Genet.2010153B491993620127885
  • StrandwitzPKimKHTerekhovaDet al.GABA-modulating bacteria of the human gut microbiota.Nat Microbiol.2019439640330531975
  • ClinicalTrials.gov [Internet] Bethesda US National Library of Medicine Available from: www.clinicaltrials.gov
  • MarkhamABainsRFranklinPSpeddingM.Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF?Br J Pharmacol.201417182206222924720259